Indigo offers a generalist care offer in response to the increasing demand for care and the changing playing field. Generalist care is offered by Indigo in or near the GP practice, is accessible, does not unnecessarily medicalise and is immediately accessible without waiting times. This care meets the needs of a large group of clients, who are now receiving specialist mental health care in the second line.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL

THERMO FISHER SCIENTIFIC OPENS BIOPROCESSING MANUFACTURING SITE IN OGDEN, UTAH

Thermo Fisher Scientific | April 21, 2022

news image

Thermo Fisher Scientific today celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah. The state-of-the-art facility creates additional capacity to produce the high-quality technology and materials needed for the development of new vaccines and breakthrough therapies. The $44 million facility is part of Thermo Fisher’s $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity ...

Read More

MEDICAL

NOVALIS BIOTECH ANNOUNCES THE CLOSING OF A €25 MILLION BIOTECH ACCELERATION FUND

Novalis Biotech | July 01, 2021

news image

Novalis Biotech, an early-stage venture capital investor in healthcare-related technology, announced today the completion of its €25 million second fund, the Novalis Biotech Acceleration Fund. The fundraising has included both new and returning investors. The second fund's investor base comprises institutional investors, including Participate Maatschappij Vlaanderen (PMV), family offices, and high-net-worth individuals (HNWIs). The Biotech Acceleration Fund will continue ...

Read More

CELL AND GENE THERAPY

LUNAPHORE AND NUCLEAI ANNOUNCE A PARTNERSHIP TO PROVIDE AIPOWERED SPATIAL BIOLOGY ANALYSIS TO ACCELERATE DRUG DEVELOPMENT

Lunaphore and Nucleai | September 09, 2022

news image

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest spatial imaging and machine learning technologies. “We are thrilled to announce the partnership with Lunaphore and...

Read More

MEDTECH

GREENLIGHT BIOSCIENCES AND SAMSUNG BIOLOGICS COMPLETE FIRST COMMERCIAL-SCALE ENGINEERING RUN FOR MRNA COVID-19 VACCINE

Samsung Biologics | August 02, 2022

news image

GreenLight Biosciences a biotechnology company dedicated to making ribonucleic acid products affordable and accessible for human health and agriculture, and Samsung Biologics a leading global CDMO providing fully integrated end-to-end contract development and manufacturing services, announced the successful completion of the first commercial-scale engineering run for the companies' mRNA production partnership. Since the announcement of the strategic partnership between GreenLi...

Read More
news image

MEDICAL

THERMO FISHER SCIENTIFIC OPENS BIOPROCESSING MANUFACTURING SITE IN OGDEN, UTAH

Thermo Fisher Scientific | April 21, 2022

Thermo Fisher Scientific today celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah. The state-of-the-art facility creates additional capacity to produce the high-quality technology and materials needed for the development of new vaccines and breakthrough therapies. The $44 million facility is part of Thermo Fisher’s $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity ...

Read More
news image

MEDICAL

NOVALIS BIOTECH ANNOUNCES THE CLOSING OF A €25 MILLION BIOTECH ACCELERATION FUND

Novalis Biotech | July 01, 2021

Novalis Biotech, an early-stage venture capital investor in healthcare-related technology, announced today the completion of its €25 million second fund, the Novalis Biotech Acceleration Fund. The fundraising has included both new and returning investors. The second fund's investor base comprises institutional investors, including Participate Maatschappij Vlaanderen (PMV), family offices, and high-net-worth individuals (HNWIs). The Biotech Acceleration Fund will continue ...

Read More
news image

CELL AND GENE THERAPY

LUNAPHORE AND NUCLEAI ANNOUNCE A PARTNERSHIP TO PROVIDE AIPOWERED SPATIAL BIOLOGY ANALYSIS TO ACCELERATE DRUG DEVELOPMENT

Lunaphore and Nucleai | September 09, 2022

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest spatial imaging and machine learning technologies. “We are thrilled to announce the partnership with Lunaphore and...

Read More
news image

MEDTECH

GREENLIGHT BIOSCIENCES AND SAMSUNG BIOLOGICS COMPLETE FIRST COMMERCIAL-SCALE ENGINEERING RUN FOR MRNA COVID-19 VACCINE

Samsung Biologics | August 02, 2022

GreenLight Biosciences a biotechnology company dedicated to making ribonucleic acid products affordable and accessible for human health and agriculture, and Samsung Biologics a leading global CDMO providing fully integrated end-to-end contract development and manufacturing services, announced the successful completion of the first commercial-scale engineering run for the companies' mRNA production partnership. Since the announcement of the strategic partnership between GreenLi...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us